JP2022500387A5 - - Google Patents

Info

Publication number
JP2022500387A5
JP2022500387A5 JP2021513331A JP2021513331A JP2022500387A5 JP 2022500387 A5 JP2022500387 A5 JP 2022500387A5 JP 2021513331 A JP2021513331 A JP 2021513331A JP 2021513331 A JP2021513331 A JP 2021513331A JP 2022500387 A5 JP2022500387 A5 JP 2022500387A5
Authority
JP
Japan
Prior art keywords
containing seq
chain variable
variable domain
cdr1
cdr2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021513331A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022500387A (ja
Filing date
Publication date
Priority claimed from NL2021589A external-priority patent/NL2021589B1/en
Application filed filed Critical
Priority claimed from PCT/NL2019/050576 external-priority patent/WO2020055240A1/en
Publication of JP2022500387A publication Critical patent/JP2022500387A/ja
Publication of JP2022500387A5 publication Critical patent/JP2022500387A5/ja
Priority to JP2024191894A priority Critical patent/JP2025016653A/ja
Pending legal-status Critical Current

Links

JP2021513331A 2018-09-10 2019-09-05 Ｍｕｓｋ阻害 Pending JP2022500387A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024191894A JP2025016653A (ja) 2018-09-10 2024-10-31 Ｍｕｓｋ阻害

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
NL2021589 2018-09-10
NL2021589A NL2021589B1 (en) 2018-09-10 2018-09-10 MuSK inhibition
NL2023119 2019-05-13
NL2023119 2019-05-13
PCT/NL2019/050576 WO2020055240A1 (en) 2018-09-10 2019-09-05 Musk inhibition

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024191894A Division JP2025016653A (ja) 2018-09-10 2024-10-31 Ｍｕｓｋ阻害

Publications (2)

Publication Number Publication Date
JP2022500387A JP2022500387A (ja) 2022-01-04
JP2022500387A5 true JP2022500387A5 (https=) 2022-09-14

Family

ID=68138766

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021513331A Pending JP2022500387A (ja) 2018-09-10 2019-09-05 Ｍｕｓｋ阻害
JP2024191894A Pending JP2025016653A (ja) 2018-09-10 2024-10-31 Ｍｕｓｋ阻害

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024191894A Pending JP2025016653A (ja) 2018-09-10 2024-10-31 Ｍｕｓｋ阻害

Country Status (8)

Country Link
US (1) US20220002438A1 (https=)
EP (1) EP3850014A1 (https=)
JP (2) JP2022500387A (https=)
CN (1) CN113614112A (https=)
AU (1) AU2019337338A1 (https=)
CA (1) CA3112288A1 (https=)
IL (1) IL281409A (https=)
WO (1) WO2020055240A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114487448B (zh) * 2022-01-21 2022-10-18 天津天海新域生物科技有限公司 用于检测重症肌无力相关抗体的组合物、试剂盒及应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5204244A (en) 1987-10-27 1993-04-20 Oncogen Production of chimeric antibodies by homologous recombination
US5202238A (en) 1987-10-27 1993-04-13 Oncogen Production of chimeric antibodies by homologous recombination
US5814478A (en) 1995-12-15 1998-09-29 Regeneron Pharmaceuticals, Inc. Tyrosine kinase receptors and ligands
CA2453822C (en) 2001-08-03 2011-02-22 Tyco Healthcare Group Lp Tissue marking apparatus and method
EP1423133B1 (en) * 2001-08-15 2009-01-14 Brown University Research Foundation Treatment of muscular dystrophies and related disorders
US6921538B2 (en) 2002-05-10 2005-07-26 Allergan, Inc. Therapeutic treatments for neuropsychiatric disorders
US7807378B2 (en) * 2005-12-29 2010-10-05 Industrial Technology Research Institute (Itri) Method of diagnosing myasthenia gravis and kits therefor
CN101490085A (zh) * 2006-06-12 2009-07-22 特鲁比昂药品公司 具有效应功能的单链多价结合蛋白
JP2011207769A (ja) * 2010-03-29 2011-10-20 Arubion:Kk 化粧料及び皮膚外用剤
JP2014520148A (ja) * 2011-06-20 2014-08-21 セントルイス ユニバーシティ 治療のための神経筋接合部への標的化
WO2013074636A1 (en) * 2011-11-14 2013-05-23 New York University Muscle specific receptor kinase and modulation thereof
US9574015B2 (en) * 2013-09-13 2017-02-21 New York University Methods for treating muscle specific receptor kinase (MuSK) myasthenia gravis with the Ig1 domain of MuSK
JP7023840B2 (ja) * 2015-10-07 2022-02-22 メモリアル スローン ケタリング キャンサー センター 神経筋接合活性のモジュレーターを同定するｉｎ ｖｉｔｒｏの方法

Similar Documents

Publication Publication Date Title
JP2020062036A5 (https=)
JP2021191763A5 (https=)
IL295230A (en) Combination therapy with anti-cd73 antibodies
JP2021098733A5 (https=)
JP2009541492A5 (https=)
IL273424B2 (en) Novel bispecific cd3/cd19 polypeptide complexes
JP2019513701A5 (https=)
JP2015500207A5 (https=)
JP2020533311A5 (ja) ＮＫＧ２Ｄ、ＣＤ１６およびＮｅｃｔｉｎ４に結合するタンパク質
HRP20230344T1 (hr) Protutijela protiv sortilina i postupci njihove upotrebe
RU2019140602A (ru) АНТИ-GARP-TGF-β-АНТИТЕЛА
JP2009530423A5 (https=)
JP2019536470A5 (https=)
JP2019509055A5 (https=)
WO2006121852A3 (en) Anti-cd19 antibody therapy for autoimmune disease
PE20091474A1 (es) Anticuerpos monoclonales contra la proteina rgm a y sus usos
JP2018535948A5 (https=)
HRP20120701T1 (hr) Humana monoklonska protutijela protiv fukozil-gm1 i postupci za uporabu antifukozil-gm1
JP2018503365A5 (https=)
JP2019527194A5 (https=)
JP2023532129A5 (https=)
RU2009136913A (ru) Биспецифические связывающие агенты с межвидовой специфичностью
JP2024016024A5 (https=)
JP2015504421A5 (https=)
JP2021520201A5 (https=)